Atlas Trials

TMC435-TiDP16-C108 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Digoxin and Between TMC435 and Rosuvastatin

Clinical trial NCT01288742 · COMPLETED

Trial details

NCT number
NCT01288742
Sponsor
Tibotec Pharmaceuticals, Ireland
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C Virus
Start date
2011-01-01
Primary completion
2011-05-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.